Company Overview

Novo Nordisk is a multinational pharmaceutical company on a mission to defeat diabetes and other chronic illnesses.

Headquarters

Bagsværd, Denmark

Employees

50,000 - 75,000

Website
https://www.novonordisk.com/

Value as a service

€45M
Savings Annually
99%
Of Sourcing Events through Coupa
95%
Global PO Coverage

Challenge

Low spend transparency and data collection due to using multiple point solutions for the procure-to-pay (P2P) process.

With different systems in use, purchasing lab equipment was too complicated for researchers — leading to poor user adoption and saving leakages.

The need to digitize sourcing and contract management to reduce risk and drive additional savings.

Results

Using a single suite solution that covers the entire procurement process brings a holistic view of spend — from category strategy to payments — and enables better resource allocation.

Achieving high user adoption for global employees and improved compliance thanks to a user-friendly platform with automated workflows.

Enabling better supplier and partner collaboration with 99% of sourcing and 100% of contract management happening digitally.

“It’s really exciting that procurement and our digital transformation is now supporting the growth of the company and also our ability to deliver on our promises to customers.”

— Martin Fog, VP, Corporate Procurement, Processes & Digitalisation